Empowering innovative therapies in respiratory care to reach patients faster
Respiratory diseases are among the most prevalent disease categories globally, encompassing a wide range of conditions including various chronic airway diseases, acute and chronic respiratory infections, and interstitial lung diseases. These conditions not only affect patients' respiratory function and quality of life, but may also trigger multi-system complications, imposing a heavy social and healthcare burden.
Guangzhou Evidence-Based Medicine Co., Ltd. has managed multiple respiratory disease clinical trial projects with extensive and professional operational experience. We maintain long-term collaborations with KOLs from respiratory medicine departments of multiple top-tier hospitals and possess abundant respiratory expert resources. We also maintain close partnerships with the Guangzhou Institute of Respiratory Health, leveraging its leading position in the domestic respiratory field to provide strong academic and clinical support for various projects.
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.
